3rd Quarter - Report

ASCENSION HEALTH ALLIANCE D/B/A ASCENSION for ASCENSION HEALTH ALLIANCE D/B/A ASCENSION

Firm
Client
Income
—
Expenses
$1,100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Affordable prescription drugs, 340B program, drug shortages

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Immigration IMM

Supported maintaining the current definition of Public Charge to ensure continued access to Medicaid and other federal assistance programs.

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA)

Veterans VET

Implementation of the Mission Act

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: SENATE; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Affordable prescription drugs, 340B Program, HR985 FAST Generics Act of 2019, Appropriate and accurate payment for healthcare, Site Neutral payment policies, S. 1895 - Lower Health Care Costs Act, S. 340 - CREATES Act, H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act, S. 1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019, Surprise billing: S. 1531 - Stop the Outrageous Practice of Surprise Medical Bills Act of 2019; HR 3, the Lower Drug Costs Now Act; H.R.2149 - Exposing the Financing of Human Trafficking Act; H.R.508 - Trafficking Victims Housing Act of 2019

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: SENATE; Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 1531 (116th), H.R. 985 (116th), S. 1895 (116th), S. 340 (116th), H.R. 3 (116th), H.R. 987 (116th), H.R. 2149 (116th), H.R. 508 (116th), S. 1391 (116th)

Medicare/Medicaid MMM

Site Neutral payment policies, Medicare for All, Medicare Buy In, Affordable prescription drugs, Medicaid DSH, Medicare bad debt, wage index, modernization of the Stark Law and Anti-Kickback statutes

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Religion REL

Religious freedom and conscience protection.

LobbyistCovered position, as disclosed
MARK HAYES —
BROCK INGMIRE —
PETER LEIBOLD —
DANIELLE WHITE —

Contacted: Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.